Company name:

Teladoc Health Inc

  • IPO SHARE PRICE:
    $19.00
  • IPO DATE:
    July 01, 2015
  • TICKER:
    TDOC
  • MAIN STOCK EXCHANGE:
    New York Stock Exchange
  • CURRENT HQ LOCATION:
    2 Manhattanville Road Suite 203 Purchase New York 10577
  • FISCAL YEAR END:
    December 31
  • INCORPORATION JURISDICTION:
    DE
  • ORGANIZED AS THE FOLLOWING LEGAL TYPE:
    Corporation
  • Investor Relations Webpage:
    Coming soon!
  • TAX RATE:
    USA federal corporate nominal income tax rate is 21%

Short Description

Teladoc Health Inc

We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com

Income Statement

(USD in thousand)
Selected Year:
31-Dec
2020
Revenue
Gross receipts in the form of cash (great!) and promises to pay (Account Receivables - not so great as some of them will never be collected but reality of business!) from all its customers
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Total Revenue
45,679
45,679
45,679
45,679
233,279 417,907 553,307 1,093,962 1,093,962 1,533,284
Selected Year:
31-Dec
2020
Operating expenses
Cost (labor, materials, depreciation, overhead, etc) for delivering service or manufacturing a product that business sells
146.3%
45.5%

General and administrative

35.7%

Cost of revenue excluding depreciation and amortization

20.7%

Marketing and advertising

15.1%

Product technology and development

14.1%

Sales

8.1%

Acquisition and integration related costs

6.4%

Depreciation and amortization

0.8%

Legal and regulatory expenses

0.0%

Gain on sale

Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Cost of revenue
45,679
45,679
45,679
45,679
61,623 128,735 - - - -
Cost of revenue excluding depreciation and amortization Cost of revenue excluding depreciation and amortization
-
-
-
-
61,623 128,735 184,465 390,829 390,829 491,768
Sales
45,679
45,679
45,679
45,679
37,984 59,154 64,915 154,052 154,052 375,768
Gross profit
45,679
45,679
45,679
45,679
171,656 289,172 - - - -
Marketing and advertising
45,679
45,679
45,679
45,679
57,663 85,109 109,697 226,146 226,146 375,004
Product technology and development
45,679
45,679
45,679
45,679
34,459 54,373 64,644 164,941 164,941 370,788
General and administrative
45,679
45,679
45,679
45,679
79,781 116,916 157,694 497,808 497,808 1,365,500
Legal and regulatory expenses
-
45,679
45,679
45,679
4,872 3,981 6,762 8,876 8,876 10,440
Acquisition and integration related costs
-
-
45,679
45,679
13,196 10,391 6,620 88,236 88,236 230,200
Acquisition-related costs
-
45,679
-
-
- - - - - -
Depreciation and amortization
45,679
45,679
45,679
45,679
19,095 35,602 38,952 69,495 69,495 147,840
Gain on sale
-
-
-
-
- (5,500) - - - -
Total operating expenses
45,679
45,679
45,679
45,679
- - - - - -
Total expenses
-
-
-
-
308,673 488,761 633,749 1,600,383 1,600,383 3,367,308
Selected Year:
31-Dec
2020
Operating Income
Income after excluding Operating Expenses from Total Revenue
46.3%
46.3%

Operating Income

Key metric that shows earnings potential of the company's business model
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Operating income
$45,679
$45,679
$45,679
$45,679
($75,394) ($70,854) ($80,442) ($506,421) ($506,421) ($1,834,024)
Selected Year:
31-Dec
2020
Non-operating expenses
Cost usually unrelated to delivering service or manufacturing a product that business sells
0.8%
0.8%

Loss on early repayment of debt

Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Loss on early repayment of debt
-
-
-
-
- - - 9,077 9,077 396
Amortization of warrants and loss on early repayment of debt
-
45,679
45,679
45,679
14,122 - - - - -
Total non-operating income (expense)
45,679
45,679
45,679
45,679
14,122 - - 9,077 9,077 396
Selected Year:
31-Dec
2020
Earnings before Interest and Taxes (EBIT)
Income after excluding Operating and Non-operating Expenses from Total Revenue
45.5%
45.5%

EBIT

Another income metric but unlike Operating Income it is closer to the ultimate income metric - Net Income by removing expenses that are not related to earning Revenue as they are supposed to be accidental and transitory
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
EBIT
$45,679
$45,679
$45,679
$45,679
($61,272) ($70,854) ($80,442) ($497,344) ($497,344) ($1,833,628)
Selected Year:
31-Dec
2020
Interest Expense and Income, Taxes
Expenses driven mostly by company management's choices, nature of business (capital intensive vs not) about financing (debt vs equity) and legal structure
2.8%
8.3%

Income tax expense or benefit

5.5%

Interest expense

Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Interest expense (income)
45,679
-
-
-
- - - - - -
Interest expense
-
45,679
45,679
45,679
17,491 26,112 29,013 60,495 60,495 83,276
Income before income taxes
45,679
45,679
45,679
45,679
(107,007) (96,966) (109,455) (575,993) (575,993) (1,917,696)
Income tax expense or benefit
45,679
45,679
45,679
45,679
(225) 118 (10,591) (90,857) (90,857) (341,828)
Selected Year:
31-Dec
2020
Net income (loss)
Ultimate measure of Income - Net result after excluding all expenses from Total Revenue
44.3%
44.3%

Net income (loss)

It is a residue that is left from Total Revenue after paying all kind of expenses and belongs to all equity holders in the company. Some of these shareholders such Non-controlling interest or Preferred equity gets their share before Common shareholders
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net income (loss)
$45,679
$45,679
$45,679
$45,679
($106,782) ($97,084) ($98,864) ($485,136) ($485,136) ($1,575,868)

Basic Shares Outstanding
Basic shares outstanding as of certain dates reported by Company on its annual and quarterly filings, these numbers are NOT used calculation of basic EPS. They help to see share issuance by company in perspective
Common
-
-
45,678,795
61,726,438
45,678,795 70,766,778 73,008,312 152,699,999 152,699,999 152,699,999
Selected Year:
31-Dec
2020
EPS
Net Income / Shares Outstanding = EPS before dilution or Basic EPS; Net Income/ ( Shares Outstanding + potentially available shares from conversion of various option instruments)
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net Income per basic share
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
($1.93) ($1.47) ($1.38) ($5.36) ($5.36) ($16.76)
Net Income per diluted share
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
($1.93) ($1.47) ($1.38) ($5.36) ($5.36) ($16.76)